Search

Corporate Sponsor Program

View the EHA Ranking 2025

"Alone we can do so little; together we can do so much.

Read more

Priority Points System

The Priority Points System is designed to recognize sponsors’ investment and continuous support for EHA activities, and are allocated for each sponsorship program and/or item.

Read more

Research & Mentoring

One of EHA’s key pillars is investing in future leaders in hematology.

Read more

Call for interest — new La Cantera event

The call for interest is open until 23:59 on November 30, 2024. Complete the Word application form now

In 2025, EHA will provide funding for a new La Cantera coaching event.

Read more

General Information

June 5, 2025
EHA2025 Congress platform opens

June 12-15, 2025
EHA2025 Milan, Italy - In-person and live stream

Location 
Allianz MiCo, Milano Convention Centre

August 15, 2025
EHA2025 Congress platform closes

 
 

Scientific Program Committee (SPC) Chair
Prof.

Read more

Clinical Research Training in Hematology

The CRTH 2025 call for applications is now closed. What is Clinical Research Training in Hematology (CRTH)?Clinical Research Training in Hematology (CRTH) provides early-career researchers with a unique, 9-month long training and mentoring experience.

Read more

EHA-EMBL/EBI Computational Biology Training in Hematology

The CBTH 2025 call for applications is now closed.

Read more

Guidelines Committee

Current committee members
Carlo Dufour, Italy (Chair)
Martin Dreyling, Germany (Vice-Chair)
Steffen Koschmieder, Germany (Executive member)
Marieke Kruip, The Netherlands (Executive member)
Area associate members
Tamam Bakchoul, Germany
Sabine Blum, Switzerland 
Cristina Castilla Llorente, France 
Lydie Da Costa, France
Wojciech Jurczak, Poland
Noémi Roy, United Kingdom
Giovanna Russo, Italy
Cynthia So-Osman, The Netherlands
AimThe…

Read more

Adolescents and young adults (AYA)

Spotlight on AYAAdolescents and young adults (AYA) with hematologic diseases are a unique group with special characteristics and needs. In recent years, the challenges related to the management of AYA (particularly in relation to cancer) have increasingly been recognized.

Read more